Clinical research on high myopia treatments using AMARIS trans-epithelial PRK

Abstract

AIM:To evaluate the efficiency and safety of high myopia treatments using AMARIS trans-epithelial photorefractive keratectomy(PRK).METHODS:One hundred and thirty six eyes in 68 patients with high myopic were treated using Amaris trans-epithelial PRK during December 2012～December 2013. Post-operative pain, haze, visual acuity, refraction and intraocular pressure(IOP)were analyzed during 12mo follow-up post-operatively.RESULTS:One hundred and eight eyes in 54 patients felt no discomfort at all, while 28 eyes in 14 patients reported dry eye, slight pain and foreign body sensation. UCVA between the two groups showed statistically different at 3, 6mo and 1a(t=2.04, P=0.047). UCVA at 3mo was the best compared with those at other time pionts, and became stable at 6mo. UCVA of all patients were above 0.8 at 12mo,and had no difference with that before operations(t=1.508, P=0.1670). Haze were hardly seen, and most of them were between grade 0～1. The patients' satisfaction was over 85% according to the survey about night vision, dry eye and asthenopia.CONCLUSION:Because of the great advantages of no-touch, fast recovery and less side effects, trans-epithelial PRK has great efficiency, safety and satisfaction. It now is the most ideal method of surface ablation for high myopia treatments.

Keywords

• trans-epithelial photorefractive keratectomy
• high myopia
• corneal surface ablation surgery
• cornea
• full laser